155 related articles for article (PubMed ID: 32267349)
1. Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy.
Brilli L; Calabrò L; Campanile M; Pilli T; Agostinis C; Cerase A; Maio M; Castagna MG
Arch Endocrinol Metab; 2020 Aug; 64(4):483-486. PubMed ID: 32267349
[TBL] [Abstract][Full Text] [Related]
2. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
[TBL] [Abstract][Full Text] [Related]
3. Central Diabetes Insipidus Due to IgG4-related Hypophysitis That Required over One Year to Reach the Final Diagnosis Due to Symptoms Being Masked by Sialadenitis.
Iwamoto Y; Mori S; Tatsumi F; Sugisaki T; Dan K; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
Intern Med; 2022 Dec; 61(23):3541-3545. PubMed ID: 35569983
[TBL] [Abstract][Full Text] [Related]
4. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
[TBL] [Abstract][Full Text] [Related]
5. Anti-PD-L1 Treatment Induced Central Diabetes Insipidus.
Zhao C; Tella SH; Del Rivero J; Kommalapati A; Ebenuwa I; Gulley J; Strauss J; Brownell I
J Clin Endocrinol Metab; 2018 Feb; 103(2):365-369. PubMed ID: 29220526
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system.
Maghnie M; Altobelli M; Di Iorgi N; Genovese E; Meloni G; Manca-Bitti ML; Cohen A; Bernasconi S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1891-6. PubMed ID: 15070961
[TBL] [Abstract][Full Text] [Related]
7. 'If there were water we should stop and drink': neurofibromatosis presenting with diabetes insipidus.
Barry R; O' Connor A; Awang MH; O' Toole O
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440241
[TBL] [Abstract][Full Text] [Related]
8. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic hypophysitis with a long latent period from onset of central diabetes insipidus to development of pituitary enlargement.
Akahori H; Sugimoto T
Intern Med; 2010; 49(15):1565-71. PubMed ID: 20686292
[TBL] [Abstract][Full Text] [Related]
10. Central diabetes insipidus: a previously unreported side effect of temozolomide.
Faje AT; Nachtigall L; Wexler D; Miller KK; Klibanski A; Makimura H
J Clin Endocrinol Metab; 2013 Oct; 98(10):3926-31. PubMed ID: 23928668
[TBL] [Abstract][Full Text] [Related]
11. Manifestation of Central Diabetes Insipidus in a Patient with Thyroid Storm.
Nakamichi A; Ocho K; Oka K; Yasuda M; Hasegawa K; Iwamuro M; Obika M; Rai K; Otsuka F
Intern Med; 2018 Jul; 57(13):1939-1942. PubMed ID: 29491282
[TBL] [Abstract][Full Text] [Related]
12. [Central diabetes insipidus: diagnostic difficulties].
Matoussi N; Aissa K; Fitouri Z; Hajji M; Makni S; Bellagha I; Ben Becher S
Ann Endocrinol (Paris); 2008 Jun; 69(3):231-9. PubMed ID: 18486932
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Central Diabetes Insipidus That Was Caused by Pituitary Metastasis of Lung Adenocarcinoma and Was Controlled by Radiation Therapy].
Izumi Y; Masuda T; Nabeshima S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Murakami Y; Hamada H; Nagata Y; Hattori N
Gan To Kagaku Ryoho; 2017 Jun; 44(6):513-516. PubMed ID: 28698444
[TBL] [Abstract][Full Text] [Related]
14. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
[TBL] [Abstract][Full Text] [Related]
15. A Rare Case of Familial Neurogenic Diabetes Insipidus in a 22-Year-Old Man.
Phan VTT; Bloomer ZW; Phan VTX; Shakir MKM; Hoang TD
AACE Clin Case Rep; 2021; 7(6):338-341. PubMed ID: 34765727
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature].
Miyagi K; Shingaki T; Ito K; Koga H; Mekaru S; Kinjo T; Arakaki Y; Nakasone S
No Shinkei Geka; 1997 Feb; 25(2):169-75. PubMed ID: 9027895
[TBL] [Abstract][Full Text] [Related]
17. Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Yamazaki M; Sato A; Nishio S; Uehara T; Komatsu M
Intern Med; 2010; 49(17):1885-90. PubMed ID: 20823651
[TBL] [Abstract][Full Text] [Related]
18. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
[TBL] [Abstract][Full Text] [Related]
19. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Ishay A; Shacham EC
BMC Endocr Disord; 2023 Feb; 23(1):47. PubMed ID: 36810011
[TBL] [Abstract][Full Text] [Related]
20. Diabetes insipidus secondary to nivolumab-induced neurohypophysitis and pituitary metastasis.
Fosci M; Pigliaru F; Salcuni AS; Ghiani M; Cherchi MV; Calia MA; Loviselli A; Velluzzi F
Endocrinol Diabetes Metab Case Rep; 2021 Jan; 2021():. PubMed ID: 33522491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
